BMRA - Biomerica, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 28.23M
Enterprise Value 24.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.36
Price/Book (mrq)3.90
Enterprise Value/Revenue 2.56
Enterprise Value/EBITDA -3.73

Trading Information

Stock Price History

Beta (5Y Monthly) -0.63
52-Week Change 3-56.00%
S&P500 52-Week Change 31.77%
52 Week High 35.2500
52 Week Low 31.0800
50-Day Moving Average 31.6126
200-Day Moving Average 32.8912

Share Statistics

Avg Vol (3 month) 347.42k
Avg Vol (10 day) 354.56k
Shares Outstanding 516.82M
Implied Shares Outstanding 6N/A
Float 815.58M
% Held by Insiders 17.15%
% Held by Institutions 125.68%
Shares Short (May 14, 2023) 4312.28k
Short Ratio (May 14, 2023) 46.34
Short % of Float (May 14, 2023) 42.00%
Short % of Shares Outstanding (May 14, 2023) 41.86%
Shares Short (prior month Apr 13, 2023) 4402.45k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Nov 13, 1994

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2022
Most Recent Quarter (mrq)Feb 27, 2023

Profitability

Profit Margin -74.55%
Operating Margin (ttm)-74.93%

Management Effectiveness

Return on Assets (ttm)-34.65%
Return on Equity (ttm)-90.28%

Income Statement

Revenue (ttm)9.53M
Revenue Per Share (ttm)0.72
Quarterly Revenue Growth (yoy)-85.50%
Gross Profit (ttm)2.98M
EBITDA -6.84M
Net Income Avi to Common (ttm)-7.11M
Diluted EPS (ttm)-0.5100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.35M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)1.18M
Total Debt/Equity (mrq)19.68
Current Ratio (mrq)4.65
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)-8.77M
Levered Free Cash Flow (ttm)-6.07M